nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—CYP2A6—Ifosfamide—testicular cancer	0.097	0.149	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0663	0.102	CbGbCtD
Amiodarone—CYP3A7—Ifosfamide—testicular cancer	0.0663	0.102	CbGbCtD
Amiodarone—CYP3A5—Ifosfamide—testicular cancer	0.0497	0.0766	CbGbCtD
Amiodarone—CYP2C8—Ifosfamide—testicular cancer	0.0478	0.0737	CbGbCtD
Amiodarone—CYP2C19—Ifosfamide—testicular cancer	0.0401	0.0618	CbGbCtD
Amiodarone—CYP2C9—Ifosfamide—testicular cancer	0.0334	0.0514	CbGbCtD
Amiodarone—ABCB1—Dactinomycin—testicular cancer	0.0274	0.0422	CbGbCtD
Amiodarone—CYP3A5—Etoposide—testicular cancer	0.0238	0.0366	CbGbCtD
Amiodarone—CYP2C8—Etoposide—testicular cancer	0.0229	0.0352	CbGbCtD
Amiodarone—CYP3A4—Ifosfamide—testicular cancer	0.0194	0.0299	CbGbCtD
Amiodarone—CYP1A2—Etoposide—testicular cancer	0.0177	0.0273	CbGbCtD
Amiodarone—ABCB1—Vinblastine—testicular cancer	0.0172	0.0265	CbGbCtD
Amiodarone—CYP2C9—Cisplatin—testicular cancer	0.0162	0.025	CbGbCtD
Amiodarone—CYP2D6—Vinblastine—testicular cancer	0.0162	0.0249	CbGbCtD
Amiodarone—ABCB1—Cisplatin—testicular cancer	0.0157	0.0243	CbGbCtD
Amiodarone—ABCB1—Etoposide—testicular cancer	0.0155	0.0238	CbGbCtD
Amiodarone—ABCB1—Doxorubicin—testicular cancer	0.0106	0.0163	CbGbCtD
Amiodarone—CYP3A4—Vinblastine—testicular cancer	0.0103	0.0158	CbGbCtD
Amiodarone—ABCB1—Methotrexate—testicular cancer	0.0102	0.0157	CbGbCtD
Amiodarone—CYP2D6—Doxorubicin—testicular cancer	0.00994	0.0153	CbGbCtD
Amiodarone—CYP3A4—Etoposide—testicular cancer	0.00927	0.0143	CbGbCtD
Amiodarone—CYP3A4—Doxorubicin—testicular cancer	0.00632	0.00974	CbGbCtD
Amiodarone—CACNA1H—seminal vesicle—testicular cancer	0.0022	0.0664	CbGeAlD
Amiodarone—THRB—gonad—testicular cancer	0.00198	0.0598	CbGeAlD
Amiodarone—THRA—gonad—testicular cancer	0.00198	0.0598	CbGeAlD
Amiodarone—CYP2A6—seminal vesicle—testicular cancer	0.00163	0.0491	CbGeAlD
Amiodarone—THRA—female gonad—testicular cancer	0.00161	0.0486	CbGeAlD
Amiodarone—THRB—female gonad—testicular cancer	0.00161	0.0486	CbGeAlD
Amiodarone—CACNA1H—gonad—testicular cancer	0.00159	0.048	CbGeAlD
Amiodarone—THRB—testis—testicular cancer	0.00143	0.0431	CbGeAlD
Amiodarone—THRA—testis—testicular cancer	0.00143	0.0431	CbGeAlD
Amiodarone—CACNA2D2—testis—testicular cancer	0.00141	0.0426	CbGeAlD
Amiodarone—CACNA1H—female gonad—testicular cancer	0.00129	0.039	CbGeAlD
Amiodarone—SIGMAR1—seminal vesicle—testicular cancer	0.00126	0.0379	CbGeAlD
Amiodarone—CACNA1H—testis—testicular cancer	0.00115	0.0346	CbGeAlD
Amiodarone—THRB—lymph node—testicular cancer	0.00104	0.0312	CbGeAlD
Amiodarone—THRA—lymph node—testicular cancer	0.00104	0.0312	CbGeAlD
Amiodarone—CACNA2D2—lymph node—testicular cancer	0.00102	0.0309	CbGeAlD
Amiodarone—KCNH2—seminal vesicle—testicular cancer	0.000999	0.0301	CbGeAlD
Amiodarone—CACNA1H—lymph node—testicular cancer	0.000831	0.0251	CbGeAlD
Amiodarone—SIGMAR1—female gonad—testicular cancer	0.000737	0.0222	CbGeAlD
Amiodarone—SIGMAR1—testis—testicular cancer	0.000654	0.0197	CbGeAlD
Amiodarone—KCNH2—female gonad—testicular cancer	0.000587	0.0177	CbGeAlD
Amiodarone—KCNH2—testis—testicular cancer	0.00052	0.0157	CbGeAlD
Amiodarone—CYP1A1—female gonad—testicular cancer	0.000496	0.0149	CbGeAlD
Amiodarone—CYP3A5—female gonad—testicular cancer	0.000485	0.0146	CbGeAlD
Amiodarone—CYP2C8—testis—testicular cancer	0.000476	0.0144	CbGeAlD
Amiodarone—SIGMAR1—lymph node—testicular cancer	0.000474	0.0143	CbGeAlD
Amiodarone—ABCB1—embryo—testicular cancer	0.000467	0.0141	CbGeAlD
Amiodarone—ABCB1—seminal vesicle—testicular cancer	0.000438	0.0132	CbGeAlD
Amiodarone—KCNH2—lymph node—testicular cancer	0.000377	0.0114	CbGeAlD
Amiodarone—CYP2D6—female gonad—testicular cancer	0.000358	0.0108	CbGeAlD
Amiodarone—CYP1A1—lymph node—testicular cancer	0.000319	0.00961	CbGeAlD
Amiodarone—CYP2D6—testis—testicular cancer	0.000317	0.00957	CbGeAlD
Amiodarone—ABCB1—gonad—testicular cancer	0.000317	0.00955	CbGeAlD
Amiodarone—ABCB1—female gonad—testicular cancer	0.000257	0.00776	CbGeAlD
Amiodarone—ABCB1—testis—testicular cancer	0.000228	0.00688	CbGeAlD
Amiodarone—Skin disorder—Etoposide—testicular cancer	0.00018	0.000567	CcSEcCtD
Amiodarone—Erectile dysfunction—Methotrexate—testicular cancer	0.00018	0.000566	CcSEcCtD
Amiodarone—Hyperhidrosis—Etoposide—testicular cancer	0.000179	0.000564	CcSEcCtD
Amiodarone—Pancreatitis—Epirubicin—testicular cancer	0.000179	0.000564	CcSEcCtD
Amiodarone—Photosensitivity reaction—Methotrexate—testicular cancer	0.000178	0.000561	CcSEcCtD
Amiodarone—Angina pectoris—Epirubicin—testicular cancer	0.000178	0.00056	CcSEcCtD
Amiodarone—Anorexia—Etoposide—testicular cancer	0.000177	0.000556	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000176	0.000555	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000176	0.000555	CcSEcCtD
Amiodarone—Decreased appetite—Cisplatin—testicular cancer	0.000176	0.000554	CcSEcCtD
Amiodarone—Diarrhoea—Dactinomycin—testicular cancer	0.000175	0.000552	CcSEcCtD
Amiodarone—Pneumonia—Methotrexate—testicular cancer	0.000175	0.000551	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000175	0.00055	CcSEcCtD
Amiodarone—Vomiting—Bleomycin—testicular cancer	0.000175	0.00055	CcSEcCtD
Amiodarone—Pancytopenia—Epirubicin—testicular cancer	0.000173	0.000546	CcSEcCtD
Amiodarone—Hypotension—Etoposide—testicular cancer	0.000173	0.000545	CcSEcCtD
Amiodarone—Rash—Bleomycin—testicular cancer	0.000173	0.000545	CcSEcCtD
Amiodarone—Pain—Cisplatin—testicular cancer	0.000173	0.000545	CcSEcCtD
Amiodarone—Dermatitis—Bleomycin—testicular cancer	0.000173	0.000545	CcSEcCtD
Amiodarone—Hypersensitivity—Ifosfamide—testicular cancer	0.000173	0.000544	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000173	0.000543	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000172	0.000543	CcSEcCtD
Amiodarone—Muscular weakness—Doxorubicin—testicular cancer	0.000172	0.000543	CcSEcCtD
Amiodarone—Renal failure—Methotrexate—testicular cancer	0.000171	0.000539	CcSEcCtD
Amiodarone—Neutropenia—Epirubicin—testicular cancer	0.000171	0.000538	CcSEcCtD
Amiodarone—Asthenia—Ifosfamide—testicular cancer	0.000168	0.00053	CcSEcCtD
Amiodarone—Eosinophilia—Doxorubicin—testicular cancer	0.000167	0.000527	CcSEcCtD
Amiodarone—Sweating—Methotrexate—testicular cancer	0.000167	0.000525	CcSEcCtD
Amiodarone—Photosensitivity reaction—Epirubicin—testicular cancer	0.000167	0.000525	CcSEcCtD
Amiodarone—Feeling abnormal—Cisplatin—testicular cancer	0.000167	0.000525	CcSEcCtD
Amiodarone—Paraesthesia—Etoposide—testicular cancer	0.000166	0.000524	CcSEcCtD
Amiodarone—Weight increased—Epirubicin—testicular cancer	0.000166	0.000523	CcSEcCtD
Amiodarone—Pruritus—Ifosfamide—testicular cancer	0.000166	0.000523	CcSEcCtD
Amiodarone—Pancreatitis—Doxorubicin—testicular cancer	0.000166	0.000522	CcSEcCtD
Amiodarone—ABCB1—lymph node—testicular cancer	0.000165	0.00499	CbGeAlD
Amiodarone—Weight decreased—Epirubicin—testicular cancer	0.000165	0.00052	CcSEcCtD
Amiodarone—Dyspnoea—Etoposide—testicular cancer	0.000165	0.00052	CcSEcCtD
Amiodarone—Angina pectoris—Doxorubicin—testicular cancer	0.000165	0.000518	CcSEcCtD
Amiodarone—Pneumonia—Epirubicin—testicular cancer	0.000164	0.000516	CcSEcCtD
Amiodarone—Nausea—Bleomycin—testicular cancer	0.000163	0.000513	CcSEcCtD
Amiodarone—Vomiting—Dactinomycin—testicular cancer	0.000163	0.000513	CcSEcCtD
Amiodarone—Agranulocytosis—Methotrexate—testicular cancer	0.000162	0.000511	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000161	0.000508	CcSEcCtD
Amiodarone—Rash—Dactinomycin—testicular cancer	0.000161	0.000508	CcSEcCtD
Amiodarone—Decreased appetite—Etoposide—testicular cancer	0.000161	0.000507	CcSEcCtD
Amiodarone—Diarrhoea—Ifosfamide—testicular cancer	0.000161	0.000506	CcSEcCtD
Amiodarone—Pancytopenia—Doxorubicin—testicular cancer	0.00016	0.000505	CcSEcCtD
Amiodarone—Renal failure—Epirubicin—testicular cancer	0.00016	0.000504	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Etoposide—testicular cancer	0.00016	0.000504	CcSEcCtD
Amiodarone—Body temperature increased—Cisplatin—testicular cancer	0.00016	0.000504	CcSEcCtD
Amiodarone—Fatigue—Etoposide—testicular cancer	0.00016	0.000503	CcSEcCtD
Amiodarone—Neuropathy peripheral—Epirubicin—testicular cancer	0.00016	0.000503	CcSEcCtD
Amiodarone—Jaundice—Epirubicin—testicular cancer	0.000159	0.0005	CcSEcCtD
Amiodarone—Pain—Etoposide—testicular cancer	0.000158	0.000499	CcSEcCtD
Amiodarone—Constipation—Etoposide—testicular cancer	0.000158	0.000499	CcSEcCtD
Amiodarone—Neutropenia—Doxorubicin—testicular cancer	0.000158	0.000498	CcSEcCtD
Amiodarone—Hepatitis—Methotrexate—testicular cancer	0.000156	0.000492	CcSEcCtD
Amiodarone—Sweating—Epirubicin—testicular cancer	0.000156	0.000492	CcSEcCtD
Amiodarone—Dizziness—Ifosfamide—testicular cancer	0.000155	0.000489	CcSEcCtD
Amiodarone—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000154	0.000486	CcSEcCtD
Amiodarone—Weight increased—Doxorubicin—testicular cancer	0.000154	0.000484	CcSEcCtD
Amiodarone—Weight decreased—Doxorubicin—testicular cancer	0.000153	0.000482	CcSEcCtD
Amiodarone—Feeling abnormal—Etoposide—testicular cancer	0.000153	0.000481	CcSEcCtD
Amiodarone—Nausea—Dactinomycin—testicular cancer	0.000152	0.000479	CcSEcCtD
Amiodarone—Agranulocytosis—Epirubicin—testicular cancer	0.000152	0.000479	CcSEcCtD
Amiodarone—Pneumonia—Doxorubicin—testicular cancer	0.000152	0.000477	CcSEcCtD
Amiodarone—Gastrointestinal pain—Etoposide—testicular cancer	0.000152	0.000477	CcSEcCtD
Amiodarone—Visual impairment—Methotrexate—testicular cancer	0.000151	0.000474	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000149	0.00047	CcSEcCtD
Amiodarone—Vomiting—Ifosfamide—testicular cancer	0.000149	0.00047	CcSEcCtD
Amiodarone—Hypersensitivity—Cisplatin—testicular cancer	0.000149	0.000469	CcSEcCtD
Amiodarone—Bradycardia—Epirubicin—testicular cancer	0.000149	0.000469	CcSEcCtD
Amiodarone—Renal failure—Doxorubicin—testicular cancer	0.000148	0.000466	CcSEcCtD
Amiodarone—Rash—Ifosfamide—testicular cancer	0.000148	0.000466	CcSEcCtD
Amiodarone—Dermatitis—Ifosfamide—testicular cancer	0.000148	0.000465	CcSEcCtD
Amiodarone—Erythema multiforme—Methotrexate—testicular cancer	0.000148	0.000465	CcSEcCtD
Amiodarone—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000148	0.000465	CcSEcCtD
Amiodarone—Urticaria—Etoposide—testicular cancer	0.000147	0.000464	CcSEcCtD
Amiodarone—Jaundice—Doxorubicin—testicular cancer	0.000147	0.000463	CcSEcCtD
Amiodarone—Body temperature increased—Etoposide—testicular cancer	0.000146	0.000461	CcSEcCtD
Amiodarone—Abdominal pain—Etoposide—testicular cancer	0.000146	0.000461	CcSEcCtD
Amiodarone—Hepatitis—Epirubicin—testicular cancer	0.000146	0.00046	CcSEcCtD
Amiodarone—Tinnitus—Methotrexate—testicular cancer	0.000146	0.000459	CcSEcCtD
Amiodarone—Asthenia—Cisplatin—testicular cancer	0.000145	0.000457	CcSEcCtD
Amiodarone—Sweating—Doxorubicin—testicular cancer	0.000144	0.000455	CcSEcCtD
Amiodarone—Visual impairment—Epirubicin—testicular cancer	0.000141	0.000444	CcSEcCtD
Amiodarone—Agranulocytosis—Doxorubicin—testicular cancer	0.000141	0.000443	CcSEcCtD
Amiodarone—Nausea—Ifosfamide—testicular cancer	0.000139	0.000439	CcSEcCtD
Amiodarone—Diarrhoea—Cisplatin—testicular cancer	0.000138	0.000436	CcSEcCtD
Amiodarone—Erythema multiforme—Epirubicin—testicular cancer	0.000138	0.000435	CcSEcCtD
Amiodarone—Alopecia—Methotrexate—testicular cancer	0.000138	0.000435	CcSEcCtD
Amiodarone—Bradycardia—Doxorubicin—testicular cancer	0.000138	0.000434	CcSEcCtD
Amiodarone—Hypersensitivity—Etoposide—testicular cancer	0.000137	0.00043	CcSEcCtD
Amiodarone—Tinnitus—Epirubicin—testicular cancer	0.000136	0.000429	CcSEcCtD
Amiodarone—Erythema—Methotrexate—testicular cancer	0.000136	0.000428	CcSEcCtD
Amiodarone—Flushing—Epirubicin—testicular cancer	0.000136	0.000427	CcSEcCtD
Amiodarone—Hepatitis—Doxorubicin—testicular cancer	0.000135	0.000426	CcSEcCtD
Amiodarone—Dysgeusia—Methotrexate—testicular cancer	0.000133	0.000419	CcSEcCtD
Amiodarone—Asthenia—Etoposide—testicular cancer	0.000133	0.000419	CcSEcCtD
Amiodarone—Back pain—Methotrexate—testicular cancer	0.000132	0.000414	CcSEcCtD
Amiodarone—Pruritus—Etoposide—testicular cancer	0.000131	0.000413	CcSEcCtD
Amiodarone—Arrhythmia—Epirubicin—testicular cancer	0.000131	0.000411	CcSEcCtD
Amiodarone—Visual impairment—Doxorubicin—testicular cancer	0.00013	0.000411	CcSEcCtD
Amiodarone—Alopecia—Epirubicin—testicular cancer	0.000129	0.000407	CcSEcCtD
Amiodarone—Vomiting—Cisplatin—testicular cancer	0.000129	0.000405	CcSEcCtD
Amiodarone—Vision blurred—Methotrexate—testicular cancer	0.000128	0.000404	CcSEcCtD
Amiodarone—Erythema multiforme—Doxorubicin—testicular cancer	0.000128	0.000403	CcSEcCtD
Amiodarone—Rash—Cisplatin—testicular cancer	0.000128	0.000402	CcSEcCtD
Amiodarone—Dermatitis—Cisplatin—testicular cancer	0.000127	0.000401	CcSEcCtD
Amiodarone—Erythema—Epirubicin—testicular cancer	0.000127	0.000401	CcSEcCtD
Amiodarone—Diarrhoea—Etoposide—testicular cancer	0.000127	0.000399	CcSEcCtD
Amiodarone—Ill-defined disorder—Methotrexate—testicular cancer	0.000126	0.000397	CcSEcCtD
Amiodarone—Tinnitus—Doxorubicin—testicular cancer	0.000126	0.000397	CcSEcCtD
Amiodarone—Flushing—Doxorubicin—testicular cancer	0.000126	0.000395	CcSEcCtD
Amiodarone—Dysgeusia—Epirubicin—testicular cancer	0.000125	0.000392	CcSEcCtD
Amiodarone—Back pain—Epirubicin—testicular cancer	0.000123	0.000388	CcSEcCtD
Amiodarone—Malaise—Methotrexate—testicular cancer	0.000123	0.000386	CcSEcCtD
Amiodarone—Dizziness—Etoposide—testicular cancer	0.000123	0.000386	CcSEcCtD
Amiodarone—Vertigo—Methotrexate—testicular cancer	0.000122	0.000385	CcSEcCtD
Amiodarone—Arrhythmia—Doxorubicin—testicular cancer	0.000121	0.000381	CcSEcCtD
Amiodarone—Nausea—Cisplatin—testicular cancer	0.00012	0.000378	CcSEcCtD
Amiodarone—Vision blurred—Epirubicin—testicular cancer	0.00012	0.000378	CcSEcCtD
Amiodarone—Alopecia—Doxorubicin—testicular cancer	0.00012	0.000376	CcSEcCtD
Amiodarone—Cough—Methotrexate—testicular cancer	0.000119	0.000374	CcSEcCtD
Amiodarone—Ill-defined disorder—Epirubicin—testicular cancer	0.000118	0.000372	CcSEcCtD
Amiodarone—Vomiting—Etoposide—testicular cancer	0.000118	0.000371	CcSEcCtD
Amiodarone—Erythema—Doxorubicin—testicular cancer	0.000118	0.000371	CcSEcCtD
Amiodarone—Agitation—Epirubicin—testicular cancer	0.000117	0.000368	CcSEcCtD
Amiodarone—Rash—Etoposide—testicular cancer	0.000117	0.000368	CcSEcCtD
Amiodarone—Dermatitis—Etoposide—testicular cancer	0.000117	0.000368	CcSEcCtD
Amiodarone—Headache—Etoposide—testicular cancer	0.000116	0.000366	CcSEcCtD
Amiodarone—Dysgeusia—Doxorubicin—testicular cancer	0.000115	0.000363	CcSEcCtD
Amiodarone—Malaise—Epirubicin—testicular cancer	0.000115	0.000361	CcSEcCtD
Amiodarone—Discomfort—Methotrexate—testicular cancer	0.000114	0.00036	CcSEcCtD
Amiodarone—Vertigo—Epirubicin—testicular cancer	0.000114	0.00036	CcSEcCtD
Amiodarone—Back pain—Doxorubicin—testicular cancer	0.000114	0.000359	CcSEcCtD
Amiodarone—Confusional state—Methotrexate—testicular cancer	0.000112	0.000352	CcSEcCtD
Amiodarone—Cough—Epirubicin—testicular cancer	0.000111	0.00035	CcSEcCtD
Amiodarone—Anaphylactic shock—Methotrexate—testicular cancer	0.000111	0.00035	CcSEcCtD
Amiodarone—Vision blurred—Doxorubicin—testicular cancer	0.000111	0.000349	CcSEcCtD
Amiodarone—Infection—Methotrexate—testicular cancer	0.00011	0.000347	CcSEcCtD
Amiodarone—Nausea—Etoposide—testicular cancer	0.00011	0.000347	CcSEcCtD
Amiodarone—Ill-defined disorder—Doxorubicin—testicular cancer	0.000109	0.000344	CcSEcCtD
Amiodarone—Thrombocytopenia—Methotrexate—testicular cancer	0.000109	0.000342	CcSEcCtD
Amiodarone—Agitation—Doxorubicin—testicular cancer	0.000108	0.000341	CcSEcCtD
Amiodarone—Anxiety—Epirubicin—testicular cancer	0.000108	0.00034	CcSEcCtD
Amiodarone—Skin disorder—Methotrexate—testicular cancer	0.000108	0.000339	CcSEcCtD
Amiodarone—Hyperhidrosis—Methotrexate—testicular cancer	0.000107	0.000338	CcSEcCtD
Amiodarone—Discomfort—Epirubicin—testicular cancer	0.000107	0.000337	CcSEcCtD
Amiodarone—Malaise—Doxorubicin—testicular cancer	0.000106	0.000334	CcSEcCtD
Amiodarone—Dry mouth—Epirubicin—testicular cancer	0.000106	0.000334	CcSEcCtD
Amiodarone—Vertigo—Doxorubicin—testicular cancer	0.000106	0.000333	CcSEcCtD
Amiodarone—Anorexia—Methotrexate—testicular cancer	0.000106	0.000333	CcSEcCtD
Amiodarone—Confusional state—Epirubicin—testicular cancer	0.000105	0.00033	CcSEcCtD
Amiodarone—Anaphylactic shock—Epirubicin—testicular cancer	0.000104	0.000327	CcSEcCtD
Amiodarone—Oedema—Epirubicin—testicular cancer	0.000104	0.000327	CcSEcCtD
Amiodarone—Hypotension—Methotrexate—testicular cancer	0.000104	0.000327	CcSEcCtD
Amiodarone—Infection—Epirubicin—testicular cancer	0.000103	0.000325	CcSEcCtD
Amiodarone—Cough—Doxorubicin—testicular cancer	0.000103	0.000324	CcSEcCtD
Amiodarone—Shock—Epirubicin—testicular cancer	0.000102	0.000322	CcSEcCtD
Amiodarone—Thrombocytopenia—Epirubicin—testicular cancer	0.000102	0.00032	CcSEcCtD
Amiodarone—Tachycardia—Epirubicin—testicular cancer	0.000101	0.000319	CcSEcCtD
Amiodarone—Skin disorder—Epirubicin—testicular cancer	0.000101	0.000318	CcSEcCtD
Amiodarone—Hyperhidrosis—Epirubicin—testicular cancer	0.0001	0.000316	CcSEcCtD
Amiodarone—Insomnia—Methotrexate—testicular cancer	0.0001	0.000316	CcSEcCtD
Amiodarone—Anxiety—Doxorubicin—testicular cancer	9.99e-05	0.000315	CcSEcCtD
Amiodarone—Paraesthesia—Methotrexate—testicular cancer	9.97e-05	0.000314	CcSEcCtD
Amiodarone—Discomfort—Doxorubicin—testicular cancer	9.91e-05	0.000312	CcSEcCtD
Amiodarone—Anorexia—Epirubicin—testicular cancer	9.9e-05	0.000312	CcSEcCtD
Amiodarone—Dyspnoea—Methotrexate—testicular cancer	9.9e-05	0.000312	CcSEcCtD
Amiodarone—Dry mouth—Doxorubicin—testicular cancer	9.8e-05	0.000309	CcSEcCtD
Amiodarone—Dyspepsia—Methotrexate—testicular cancer	9.77e-05	0.000308	CcSEcCtD
Amiodarone—Hypotension—Epirubicin—testicular cancer	9.71e-05	0.000306	CcSEcCtD
Amiodarone—Confusional state—Doxorubicin—testicular cancer	9.69e-05	0.000305	CcSEcCtD
Amiodarone—Decreased appetite—Methotrexate—testicular cancer	9.65e-05	0.000304	CcSEcCtD
Amiodarone—Oedema—Doxorubicin—testicular cancer	9.61e-05	0.000303	CcSEcCtD
Amiodarone—Anaphylactic shock—Doxorubicin—testicular cancer	9.61e-05	0.000303	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Methotrexate—testicular cancer	9.58e-05	0.000302	CcSEcCtD
Amiodarone—Fatigue—Methotrexate—testicular cancer	9.57e-05	0.000301	CcSEcCtD
Amiodarone—Infection—Doxorubicin—testicular cancer	9.55e-05	0.000301	CcSEcCtD
Amiodarone—Pain—Methotrexate—testicular cancer	9.49e-05	0.000299	CcSEcCtD
Amiodarone—Shock—Doxorubicin—testicular cancer	9.46e-05	0.000298	CcSEcCtD
Amiodarone—Thrombocytopenia—Doxorubicin—testicular cancer	9.41e-05	0.000296	CcSEcCtD
Amiodarone—Insomnia—Epirubicin—testicular cancer	9.39e-05	0.000296	CcSEcCtD
Amiodarone—Tachycardia—Doxorubicin—testicular cancer	9.38e-05	0.000295	CcSEcCtD
Amiodarone—Skin disorder—Doxorubicin—testicular cancer	9.34e-05	0.000294	CcSEcCtD
Amiodarone—Paraesthesia—Epirubicin—testicular cancer	9.33e-05	0.000294	CcSEcCtD
Amiodarone—Hyperhidrosis—Doxorubicin—testicular cancer	9.29e-05	0.000293	CcSEcCtD
Amiodarone—Dyspnoea—Epirubicin—testicular cancer	9.26e-05	0.000292	CcSEcCtD
Amiodarone—Anorexia—Doxorubicin—testicular cancer	9.16e-05	0.000288	CcSEcCtD
Amiodarone—Feeling abnormal—Methotrexate—testicular cancer	9.15e-05	0.000288	CcSEcCtD
Amiodarone—Dyspepsia—Epirubicin—testicular cancer	9.14e-05	0.000288	CcSEcCtD
Amiodarone—Gastrointestinal pain—Methotrexate—testicular cancer	9.08e-05	0.000286	CcSEcCtD
Amiodarone—Decreased appetite—Epirubicin—testicular cancer	9.03e-05	0.000284	CcSEcCtD
Amiodarone—Hypotension—Doxorubicin—testicular cancer	8.98e-05	0.000283	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Epirubicin—testicular cancer	8.97e-05	0.000282	CcSEcCtD
Amiodarone—Fatigue—Epirubicin—testicular cancer	8.95e-05	0.000282	CcSEcCtD
Amiodarone—Constipation—Epirubicin—testicular cancer	8.88e-05	0.00028	CcSEcCtD
Amiodarone—Pain—Epirubicin—testicular cancer	8.88e-05	0.00028	CcSEcCtD
Amiodarone—Urticaria—Methotrexate—testicular cancer	8.82e-05	0.000278	CcSEcCtD
Amiodarone—Abdominal pain—Methotrexate—testicular cancer	8.77e-05	0.000276	CcSEcCtD
Amiodarone—Body temperature increased—Methotrexate—testicular cancer	8.77e-05	0.000276	CcSEcCtD
Amiodarone—Insomnia—Doxorubicin—testicular cancer	8.69e-05	0.000274	CcSEcCtD
Amiodarone—Paraesthesia—Doxorubicin—testicular cancer	8.63e-05	0.000272	CcSEcCtD
Amiodarone—Dyspnoea—Doxorubicin—testicular cancer	8.57e-05	0.00027	CcSEcCtD
Amiodarone—Feeling abnormal—Epirubicin—testicular cancer	8.56e-05	0.00027	CcSEcCtD
Amiodarone—Gastrointestinal pain—Epirubicin—testicular cancer	8.49e-05	0.000267	CcSEcCtD
Amiodarone—Dyspepsia—Doxorubicin—testicular cancer	8.46e-05	0.000266	CcSEcCtD
Amiodarone—Decreased appetite—Doxorubicin—testicular cancer	8.35e-05	0.000263	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Doxorubicin—testicular cancer	8.3e-05	0.000261	CcSEcCtD
Amiodarone—Fatigue—Doxorubicin—testicular cancer	8.29e-05	0.000261	CcSEcCtD
Amiodarone—Urticaria—Epirubicin—testicular cancer	8.25e-05	0.00026	CcSEcCtD
Amiodarone—Constipation—Doxorubicin—testicular cancer	8.22e-05	0.000259	CcSEcCtD
Amiodarone—Pain—Doxorubicin—testicular cancer	8.22e-05	0.000259	CcSEcCtD
Amiodarone—Abdominal pain—Epirubicin—testicular cancer	8.21e-05	0.000259	CcSEcCtD
Amiodarone—Body temperature increased—Epirubicin—testicular cancer	8.21e-05	0.000259	CcSEcCtD
Amiodarone—Hypersensitivity—Methotrexate—testicular cancer	8.18e-05	0.000258	CcSEcCtD
Amiodarone—Asthenia—Methotrexate—testicular cancer	7.96e-05	0.000251	CcSEcCtD
Amiodarone—Feeling abnormal—Doxorubicin—testicular cancer	7.92e-05	0.000249	CcSEcCtD
Amiodarone—Gastrointestinal pain—Doxorubicin—testicular cancer	7.86e-05	0.000247	CcSEcCtD
Amiodarone—Pruritus—Methotrexate—testicular cancer	7.85e-05	0.000247	CcSEcCtD
Amiodarone—Hypersensitivity—Epirubicin—testicular cancer	7.65e-05	0.000241	CcSEcCtD
Amiodarone—Urticaria—Doxorubicin—testicular cancer	7.63e-05	0.00024	CcSEcCtD
Amiodarone—Body temperature increased—Doxorubicin—testicular cancer	7.6e-05	0.000239	CcSEcCtD
Amiodarone—Abdominal pain—Doxorubicin—testicular cancer	7.6e-05	0.000239	CcSEcCtD
Amiodarone—Diarrhoea—Methotrexate—testicular cancer	7.59e-05	0.000239	CcSEcCtD
Amiodarone—Asthenia—Epirubicin—testicular cancer	7.45e-05	0.000235	CcSEcCtD
Amiodarone—Pruritus—Epirubicin—testicular cancer	7.35e-05	0.000231	CcSEcCtD
Amiodarone—Dizziness—Methotrexate—testicular cancer	7.34e-05	0.000231	CcSEcCtD
Amiodarone—Diarrhoea—Epirubicin—testicular cancer	7.11e-05	0.000224	CcSEcCtD
Amiodarone—Hypersensitivity—Doxorubicin—testicular cancer	7.08e-05	0.000223	CcSEcCtD
Amiodarone—Vomiting—Methotrexate—testicular cancer	7.06e-05	0.000222	CcSEcCtD
Amiodarone—Rash—Methotrexate—testicular cancer	7e-05	0.00022	CcSEcCtD
Amiodarone—Dermatitis—Methotrexate—testicular cancer	6.99e-05	0.00022	CcSEcCtD
Amiodarone—Headache—Methotrexate—testicular cancer	6.95e-05	0.000219	CcSEcCtD
Amiodarone—Asthenia—Doxorubicin—testicular cancer	6.9e-05	0.000217	CcSEcCtD
Amiodarone—Dizziness—Epirubicin—testicular cancer	6.87e-05	0.000216	CcSEcCtD
Amiodarone—Pruritus—Doxorubicin—testicular cancer	6.8e-05	0.000214	CcSEcCtD
Amiodarone—Vomiting—Epirubicin—testicular cancer	6.6e-05	0.000208	CcSEcCtD
Amiodarone—Nausea—Methotrexate—testicular cancer	6.59e-05	0.000208	CcSEcCtD
Amiodarone—Diarrhoea—Doxorubicin—testicular cancer	6.58e-05	0.000207	CcSEcCtD
Amiodarone—Rash—Epirubicin—testicular cancer	6.55e-05	0.000206	CcSEcCtD
Amiodarone—Dermatitis—Epirubicin—testicular cancer	6.54e-05	0.000206	CcSEcCtD
Amiodarone—Headache—Epirubicin—testicular cancer	6.51e-05	0.000205	CcSEcCtD
Amiodarone—Dizziness—Doxorubicin—testicular cancer	6.36e-05	0.0002	CcSEcCtD
Amiodarone—Nausea—Epirubicin—testicular cancer	6.17e-05	0.000194	CcSEcCtD
Amiodarone—Vomiting—Doxorubicin—testicular cancer	6.11e-05	0.000192	CcSEcCtD
Amiodarone—Rash—Doxorubicin—testicular cancer	6.06e-05	0.000191	CcSEcCtD
Amiodarone—Dermatitis—Doxorubicin—testicular cancer	6.05e-05	0.000191	CcSEcCtD
Amiodarone—Headache—Doxorubicin—testicular cancer	6.02e-05	0.00019	CcSEcCtD
Amiodarone—Nausea—Doxorubicin—testicular cancer	5.71e-05	0.00018	CcSEcCtD
